Philip Astley-Sparke
Director · 4 filings · Latest: Jun 16, 2026
enGene Therapeutics Inc.
Replimune Group, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
REPL | Philip Astley-Sparke | Director | May 18, 2026 | Sale | $5.08 | 17,657 | $89.7K | 1,412,414 |